From the Denver Business Journal: "The funding for VitriVax comes about nine years after it was first formed by co-founders Bob Garcea and Ted Randolph, two biology professors at CU Boulder. The pair have since developed a new technology that makes vaccines thermostable —meaning they are resistant to damage from heat or cold — and delivered in just one shot." Read more here.